[go: up one dir, main page]

SE0102933D0 - Lipid carrier - Google Patents

Lipid carrier

Info

Publication number
SE0102933D0
SE0102933D0 SE0102933A SE0102933A SE0102933D0 SE 0102933 D0 SE0102933 D0 SE 0102933D0 SE 0102933 A SE0102933 A SE 0102933A SE 0102933 A SE0102933 A SE 0102933A SE 0102933 D0 SE0102933 D0 SE 0102933D0
Authority
SE
Sweden
Prior art keywords
carrier composition
bioactive substance
sail
controlled release
dispersed
Prior art date
Application number
SE0102933A
Other languages
Swedish (sv)
Inventor
Andreas Fischer
Christina Adde
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Priority to SE0102933A priority Critical patent/SE0102933D0/en
Publication of SE0102933D0 publication Critical patent/SE0102933D0/en
Priority to PCT/SE2002/001572 priority patent/WO2003020319A1/en
Priority to PCT/SE2002/001571 priority patent/WO2003020318A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention refers to a w/o-emulsion carrier composition for controlled release of a bioactive substance, which carrier composition comprises an oil phase of at least one non-polar oil, monoglycosylceramide and optionally ethanol, and an aqueous phase dispersed in sail oil phase. Said carrier composition has the ability to form a cohesive structure, which is retained in an aqueous environment. The invention also refers to a pharmaceutical formulation for controlled release of a bioactive substance, consisting of said w/o-emulsion carrier composition and a bioactive substance, dissolved or dispersed in sail carrier composition.
SE0102933A 2001-09-04 2001-09-04 Lipid carrier SE0102933D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0102933A SE0102933D0 (en) 2001-09-04 2001-09-04 Lipid carrier
PCT/SE2002/001572 WO2003020319A1 (en) 2001-09-04 2002-09-03 A w/o-emulsion carrier composition
PCT/SE2002/001571 WO2003020318A1 (en) 2001-09-04 2002-09-03 A topical w/o-emulsion composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102933A SE0102933D0 (en) 2001-09-04 2001-09-04 Lipid carrier

Publications (1)

Publication Number Publication Date
SE0102933D0 true SE0102933D0 (en) 2001-09-04

Family

ID=20285222

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102933A SE0102933D0 (en) 2001-09-04 2001-09-04 Lipid carrier

Country Status (2)

Country Link
SE (1) SE0102933D0 (en)
WO (1) WO2003020319A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013336907B2 (en) * 2012-10-25 2017-06-15 Société des Produits Nestlé S.A. Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides
US11109607B2 (en) 2013-11-18 2021-09-07 Gary Hall Oil-based compositions for enhancing oral health and general wellness in humans
WO2016081478A1 (en) * 2014-11-18 2016-05-26 Gary Hall Oil-based compositions for enhancing oral health and general wellness in humans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE9402453D0 (en) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
JP2000119178A (en) * 1998-10-13 2000-04-25 Shionogi & Co Ltd Ceramide-containing composition
SE0000730D0 (en) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier

Also Published As

Publication number Publication date
WO2003020319A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
CY1106468T1 (en) SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES
DE60020098D1 (en) Liquid polymer dispersions, their preparation and their use
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
ATE331497T1 (en) TWO-PHASE COSMETIC COMPOSITION
CL2007002095A1 (en) Topical pharmaceutical composition comprising 1- (2-methylpropyl) -1h-imidazo [4,5-c] quinolin-4-amine; packaged composition; method to sterilize it; Useful to heal tissue where the dermis has torn.
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
EE200300109A (en) Process for the preparation of a liquid emulsion composition and emulsion concentrate, pharmaceutical composition, emulsion concentrate, kit and emulsion composition
BR0116168A (en) Insect repellent formulation releasable by piezoelectric device
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
BR0211736A (en) Formulation for stabilized oral suspension
PE20070377A1 (en) LIQUID FORMULATIONS FOR THE CONTROLLED ADMINISTRATION OF BENZISOXAZOLE DERIVATIVES
BRPI0414858A (en) methods for preparing oil bodies comprising active ingredients
NO20000466L (en) Pharmaceutical preparation for acidic, lipophilic compounds in the form of a self-regulating formulation
BRPI0418330A (en) solid compositions of low solubility drugs and poloxamers
BRPI0309651B8 (en) method for preventing or reducing pesticide resistance of a substrate pest, pesticide composition, use thereof, and method for preparing a pesticide composition
DK2046292T3 (en) Formulations for benzimidazolylpyridyl ethers
SE0000730D0 (en) Lipid carrier
ATE407674T1 (en) ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR THE MODIFIED RELEASE OF AMOXICILLIN
DE60017361D1 (en) DIRECTPRESSABLE MATRIX FOR CONTROLLED DELIVERY OF ONE-ON-THE-BOTTLE CANS OF CLARITHROMYCIN
PL353738A1 (en) Composition containing an active substance, production and use thereof
CL2004001012A1 (en) COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS
BR0116152B1 (en) additive suitable for use as an emulsifier and solubilizer, use of an additive, and, composition.
SE0102933D0 (en) Lipid carrier
BRPI0514723A8 (en) compositions containing alpha-2-adrenergic agonist components
BR0215366A (en) Adhesive transdermal formulations of diclofenac sodium